Latest filing published 03 Aug 2018 for Huntsman CORP.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +5.7%Entry US$16.05 · Close at T+365 US$16.96
- +223.1%Entry US$3.46 · Close at T+365 US$11.18
- -87.0%Entry US$24.13 · Close at T+365 US$3.13
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
J. Kimo Esplin: trading record in brief
Filings by J. Kimo Esplin span 3 companies, the busiest being Nutraceutical International Corp, Huntsman Corp and Watkins Johnson Co Employee Stock Option. In total, 205 filings cover trades dated from 10 February 2006 to 16 May 2018.
The open-market side counts 37 purchases for €236k alongside 21 sales for €22.7M. The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 133 share grants and 12 option exercises. So far in 2018, the count stands at no purchases and 3 sales.
Half of the purchases are above €726 and half below. Looking at 5 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -9.1%. These figures describe past trades and do not predict future prices.
The record was last updated on 3 August 2018 with a transaction in Huntsman Corp. The last insider purchase was made public on 21 August 2015, 4,097 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to J. Kimo Esplin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,657 shares0Common StockSEC:0001214659-18-005214:0
- 5,000 shares@ US$32.730.5% of flowCommon StockSEC:0001214659-18-003862:0
- 11,106 shares@ US$32.671.1% of flowCommon StockSEC:0001214659-18-003862:1
- 34,399 shares@ US$31.813.2% of flowCommon StockSEC:0001214659-18-003840:0
- 4,993 shares0Common StockSEC:0001214659-18-001064:0
- 1,466 shares0Common StockSEC:0001214659-18-001064:1
- 4,952 shares@ US$32.460.5% of flowCommon StockSEC:0001214659-18-000913:0
- 2,235 shares@ US$32.460.2% of flowCommon StockSEC:0001214659-18-000913:1
- 32,189 shares@ US$13.501.3% of flowCommon StockSEC:0001214659-17-007215:0
- 32,189 shares@ US$31.283.0% of flowCommon StockSEC:0001214659-17-007215:1
- 75,758 shares@ US$17.854.0% of flowCommon StockSEC:0001214659-17-007215:2
- 75,758 shares@ US$31.317.1% of flowCommon StockSEC:0001214659-17-007215:3
- 59,002 shares@ US$13.412.4% of flowCommon StockSEC:0001214659-17-007215:4
- 59,002 shares@ US$31.355.5% of flowCommon StockSEC:0001214659-17-007215:5
- 19,614 shares@ US$13.410.8% of flowCommon StockSEC:0001214659-17-007215:6
- 19,614 shares@ US$30.251.8% of flowCommon StockSEC:0001214659-17-007215:7
- 54,230 shares@ US$17.592.8% of flowCommon StockSEC:0001214659-17-007215:8
- 54,230 shares@ US$30.254.9% of flowCommon StockSEC:0001214659-17-007215:9
- 428,571 shares@ US$2.593.4% of flowCommon StockSEC:0001214659-17-006302:0
- 428,571 shares@ US$31.5441.1% of flowCommon StockSEC:0001214659-17-006302:1
- 11,127.48 sharesCommon StockSEC:0001396677-17-000037:0
- 31.77 shares@ US$31.486.3% of flowCommon StockSEC:0001396677-17-000022:0
- 32.39 shares@ US$30.886.4% of flowCommon StockSEC:0001396677-17-000017:0
- 29.09 shares@ US$34.386.5% of flowCommon StockSEC:0001396677-17-000010:0
- 110,663 shares@ US$20.667.6% of flowCommon StockSEC:0001214659-17-001284:0
25 of 189 declarations